Search results for "Arterial hypertension."

showing 10 items of 63 documents

The Metabolic Syndrome and Its Relationship to Hypertensive Target Organ Damage

2007

High blood pressure is often associated with various metabolic abnormalities, including abdominal obesity, dyslipidemia, elevated plasma glucose, and insulin resistance, which are the main features of the metabolic syndrome. The metabolic syndrome is extremely common worldwide. This high prevalence is of considerable concern because several studies suggest that the metabolic syndrome carries an increased risk for cardiovascular events. Several lines of evidence seem to indicate that the metabolic syndrome is associated with an increased prevalence of preclinical cardiovascular and renal changes, such as left ventricular hypertrophy, microalbuminuria, impaired aortic elasticity, and early ca…

arterial hypertensionmedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismLeft ventricular hypertrophyRisk AssessmentInsulin resistanceRisk Factorstarget organ damageInternal medicinePrevalenceInternal MedicinemedicineHumansAbdominal obesityReview Paperbusiness.industrymedicine.diseaseMetabolic syndromeBlood pressureCardiovascular DiseasesHypertensionCardiologyMicroalbuminuriaMetabolic syndromemedicine.symptomCardiology and Cardiovascular MedicineRisk assessmentbusinessDyslipidemiaThe Journal of Clinical Hypertension
researchProduct

Bilateral double renal arteries and bilateral renal veins. A color-Doppler sonographic finding in a patient with arterial hypertension

2010

arterial hypertensionrenal arteriecolor-Doppler
researchProduct

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Ass…

2017

International audience; : Arterial hypertension accounts for the largest amount of attributable cardiovascular mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by hypertension represents an independent determinant of cardiovascular risk, and the identification of target organ damage is recommended to further reclassify patients' risk. Noninvasive cardiovascular imaging is progressively being used and continues to provide new technological opportunities to target organ damage evaluation at early stage. The aim of this article is to pr…

cardiovascular riskRiskarterial hypertensionmedicine.medical_specialtyNoninvasive imagingPhysiologyPopulation030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicinetarget organ damageInternal medicineInternal MedicineHumansMedicineIn patient030212 general & internal medicineAdverse effectIntensive care medicineeducationSocieties MedicalCardiovascular mortalitySubclinical infectionCardiac Imaging Techniqueeducation.field_of_studybusiness.industrynoninvasive cardiovascular imagingTarget organ damage3. Good healthCardiac Imaging TechniquesHypertensionPractice Guidelines as TopicCardiology[SDV.IB]Life Sciences [q-bio]/Bioengineeringmedicine.symptomCardiology and Cardiovascular MedicinebusinessprognosiHuman
researchProduct

Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients

2017

International audience; Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology …

cardiovascular riskmedicine.medical_specialtyarterial hypertension[SDV]Life Sciences [q-bio]Population030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineInternal medicinetarget organ damageMedicineRadiology Nuclear Medicine and imagingIn patient030212 general & internal medicineAdverse effecteducationnon-invasive cardiovascular imagingSubclinical infectioneducation.field_of_studybusiness.industryNon invasiveGeneral MedicineTarget organ damage3. Good healthRisk stratificationCardiologyprognosismedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice.

2020

Nonalcoholic fatty liver disease (NAFLD) is a clinical condition that encompasses various forms of liver damage not caused by chronic alcohol consumption. In the absence of other etiologies, it ranges from ste- atosis to nonalcoholic steatohepatitis and cirrhosis. The prevalence of NAFLD has considerably increased over the last years owing to the current lifestyle (unhealthy diet and sedentarism). Besides, it is associated with metabolic risk factors such as obesity, arterial hypertension, dyslipidemia, and type 2 diabetes. Given the poor prognosis of patients with advanced NAFLD, a practical therapeutic approach is necessary to halt its natural history. However, no licensed drugs have been…

medicine.medical_specialtyCirrhosisbusiness.industrynutritional and metabolic diseasesDiseaseType 2 diabetesComorbiditymedicine.diseaseObesitydigestive system diseasesArterial hypertension Dyslipidemia Nonalcoholic fatty liver disease Type 2 diabetes Comorbidity Humans Obesity Weight Loss Diabetes Mellitus Type 2 Non-alcoholic Fatty Liver DiseaseDiabetes Mellitus Type 2Weight lossNon-alcoholic Fatty Liver DiseaseInternal medicineNonalcoholic fatty liver diseaseWeight LossInternal MedicinemedicineHumansObesitymedicine.symptomSteatosisbusinessDyslipidemiaPolish archives of internal medicine
researchProduct

[OP.4B.03] CIRCULATING ALDOSTERONE LEVELS ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS

2016

OBJECTIVE: Sound evidence indicates that aldosterone has a fundamental role in determining functional and structural changes in the heart. Moreover, it has been observed that high plasma aldosterone concentration (PAC) is related to the development of congestive heart failure and to cardiovascular mortality. However, previous studies on the association between circulating aldosterone levels and left ventricular (LV) mass (LVM) and LV geometry, in subjects without primary aldosteronism yielded conflicting results. The aim of our study was to evaluate in patients with essential hypertension the relationships of PAC with LV mass and geometry, and to asses the influence of gender on these relat…

medicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologybusiness.industryAldosterone levelsConcentricleft ventricular hypertrophyInternal medicineInternal MedicinemedicineCardiologyLeft ventricular geometryCardiology and Cardiovascular MedicinebusinessAldosteronearterial hypertension.
researchProduct

[OP.7B.08] INFLUENCE OF GENDER ON THE RELATIONSHIPS BETWEEN NEW INDICES OF ADIPOSITY AND LEFT VENTRICULAR MASS AND HYPERTROPHY IN HYPERTENSIVE PATIEN…

2016

OBJECTIVE: The unfavourable effects of the association of obesity with hypertension on cardiac structure and function have been extensively studied. However, controversy still exists about the influence of gender on the relationship between obesity and left ventricular mass (LVM) and hypertrophy (LVH). Even if body mass index (BMI) and waist circumference (WC) are widely used as anthropometric predictors for cardiovascular diseases (CVD), their validity has been questioned. Recently, Body Shape Index (ABSI) and Body Roundness Index (BRI) were proposed as alternative measures of adiposity that may better reflect health status (1-2).Our study was aimed to assess the ability of ABSI and BRI in…

medicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologybusiness.industrySettore MED/11 - Malattie Dell'Apparato CardiovascolareMuscle hypertrophyLeft ventricular massEndocrinologyInternal medicineobesity - arterial hypertension - left ventricular hypertrophyInternal MedicinemedicineCardiologyCardiology and Cardiovascular Medicinebusiness
researchProduct

Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria

2017

The kidney is one of the major target organs of hypertension. Kidney damage represents a frequent event in the course of hypertension and arterial hypertension is one of the leading causes of end-stage renal disease (ESRD). ESRD has long been recognized as a strong predictor of cardiovascular (CV) morbidity and mortality. However, over the past 20 years a large and consistent body of evidence has been produced suggesting that CV risk progressively increases as the estimated glomerular filtration rate (eGFR) declines and is already significantly elevated even in the earliest stages of renal damage. Data was supported by the very large collaborative metaanalysis of the Chronic Kidney Disease …

medicine.medical_specialtySettore MED/09 - Medicina InternaRenal function030204 cardiovascular system & hematologyAsymptomatic03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicine030212 general & internal medicineSubclinical infectionSettore MED/14 - NefrologiaKidneyCreatinineProteinuriabusiness.industryArterial hypertension • Blood pressure • Glomerular filtration rate • Microalbuminuria • Proteinuria • Subclinical renal disease • Early kidney injury • Target organ damage • Cardiovascular disease • Cardiovascular risk assessmentmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremedicine.anatomical_structureEndocrinologychemistryCardiologyMicroalbuminuriamedicine.symptombusinessKidney disease
researchProduct

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the second international consensus conference …

2008

This document summarizes the available evidence and provides recommendations on the use of home blood pressure monitoring in clinical practice and in research. It updates the previous recommendations on the same topic issued in year 2000. The main topics addressed include the methodology of home blood pressure monitoring, its diagnostic and therapeutic thresholds, its clinical applications in hypertension, with specific reference to special populations, and its applications in research. The final section deals with the problems related to the implementation of these recommendations in clinical practice. ispartof: Journal of Hypertension vol:26 issue:8 pages:1505-1530 ispartof: location:Neth…

medicine.medical_specialtySpecial populationsPhysiologybusiness.industryMEDLINEConsensus conferenceMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring Ambulatoryguidelinesarterial hypertension cardiovascular risk home blood pressure monitoringClinical PracticeEuropeHypertensionInternal MedicinemedicineHumansBlood pressure monitoringHypertension diagnosisDrug MonitoringCardiology and Cardiovascular MedicineIntensive care medicinebusinessAntihypertensive Agents
researchProduct

European Society of Hypertension practice guidelines for home blood pressure monitoring.

2010

Self-monitoring of blood pressure by patients at home (home blood pressure monitoring (HBPM)) is being increasingly used in many countries and is well accepted by hypertensive patients. Current hypertension guidelines have endorsed the use of HBPM in clinical practice as a useful adjunct to conventional office measurements. Recently, a detailed consensus document on HBPM was published by the European Society of Hypertension Working Group on Blood Pressure Monitoring. However, in daily practice, briefer documents summarizing the essential recommendations are needed. It is also accepted that the successful implementation of clinical guidelines in routine patient care is dependent on their acc…

medicine.medical_specialtyarterial hypertensionTime FactorsOffice VisitsOffice visitsGeneral PracticeMEDLINEBlood Pressure030204 cardiovascular system & hematologyPatient care03 medical and health sciences0302 clinical medicinePredictive Value of TestsDaily practiceInternal MedicinemedicineHumansBlood pressure monitoring030212 general & internal medicineIntensive care medicineSocieties Medicalbusiness.industryMedical practiceBlood Pressure Monitoring Ambulatorymedicine.diseaseBlood Pressure Monitors3. Good healthClinical Practicehome blood pressure monitoringEuropeBlood pressuremedical practiceHypertensionPatient ComplianceMedical emergencybusiness
researchProduct